| Name | German Dobson Cvs Llc |
|---|---|
| Organization Name | German Dobson Cvs Llc |
| Location | 8055 W Bell Rd, Peoria, Arizona 85382 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (623) 979-4484 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Fate Therapeutics, Inc. announced today that the Company received Red Herring's North America 100 award, a prestigious list honoring the year's most promising private and innovative companies from the North American business region. The nominees were evaluated by the Red Herring editorial team on both quantitative and qualitative criteria, such as financial performance, technology innovation, quality of management, execution of strategy and integration into their respective industries.
The mammalian fucose mutarotase enzyme is known to be involved in incorporating the sugar fucose into protein. Female mice that lack the fucose mutarotase (FucM) gene refuse to let males mount them, and will attempt copulation with other female mice. Researchers writing in BioMed Central's open access journal BMC Genetics created the FucM mouse mutants in order to investigate the role of this enzyme in vivo.
For Canadians with chronic conditions, having a regular doctor doesn't necessarily mean they're receiving the safest or most supportive medical care. That doctor must also provide the basic elements of good primary care, two of which are: knowing their patient's history and helping to coordinate other aspects of their care, according to a Health Council of Canada bulletin released today.
Novartis today announced that both the US Food and Drug Administration and European Medicines Agency have accepted the company's New Drug Application and Marketing Authorization Application respectively, for investigational oral, once-daily siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis in adults.
ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announced today that Symphony Technology Group (STG), has acquired a majority ownership interest in the Company. STG is a leading private equity firm with a strategic focus on data, analytics and technology-enabled services companies. Merck Capital Ventures (MCV), the venture capital arm of Merck and one of ImpactRx's existing investors, will maintain its investment in ImpactRx.
› Verified 2 days ago
| NPI Number | 1659393437 |
| Organization Name | GERMAN DOBSON CVS LLC |
| Doing Business As | CVS PHARMACY #16272 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 8055 W Bell Rd, Peoria, AZ 85382 |
| Phone Number | 623-979-4484 |
News Archive
Fate Therapeutics, Inc. announced today that the Company received Red Herring's North America 100 award, a prestigious list honoring the year's most promising private and innovative companies from the North American business region. The nominees were evaluated by the Red Herring editorial team on both quantitative and qualitative criteria, such as financial performance, technology innovation, quality of management, execution of strategy and integration into their respective industries.
The mammalian fucose mutarotase enzyme is known to be involved in incorporating the sugar fucose into protein. Female mice that lack the fucose mutarotase (FucM) gene refuse to let males mount them, and will attempt copulation with other female mice. Researchers writing in BioMed Central's open access journal BMC Genetics created the FucM mouse mutants in order to investigate the role of this enzyme in vivo.
For Canadians with chronic conditions, having a regular doctor doesn't necessarily mean they're receiving the safest or most supportive medical care. That doctor must also provide the basic elements of good primary care, two of which are: knowing their patient's history and helping to coordinate other aspects of their care, according to a Health Council of Canada bulletin released today.
Novartis today announced that both the US Food and Drug Administration and European Medicines Agency have accepted the company's New Drug Application and Marketing Authorization Application respectively, for investigational oral, once-daily siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis in adults.
ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announced today that Symphony Technology Group (STG), has acquired a majority ownership interest in the Company. STG is a leading private equity firm with a strategic focus on data, analytics and technology-enabled services companies. Merck Capital Ventures (MCV), the venture capital arm of Merck and one of ImpactRx's existing investors, will maintain its investment in ImpactRx.
› Verified 2 days ago
News Archive
Fate Therapeutics, Inc. announced today that the Company received Red Herring's North America 100 award, a prestigious list honoring the year's most promising private and innovative companies from the North American business region. The nominees were evaluated by the Red Herring editorial team on both quantitative and qualitative criteria, such as financial performance, technology innovation, quality of management, execution of strategy and integration into their respective industries.
The mammalian fucose mutarotase enzyme is known to be involved in incorporating the sugar fucose into protein. Female mice that lack the fucose mutarotase (FucM) gene refuse to let males mount them, and will attempt copulation with other female mice. Researchers writing in BioMed Central's open access journal BMC Genetics created the FucM mouse mutants in order to investigate the role of this enzyme in vivo.
For Canadians with chronic conditions, having a regular doctor doesn't necessarily mean they're receiving the safest or most supportive medical care. That doctor must also provide the basic elements of good primary care, two of which are: knowing their patient's history and helping to coordinate other aspects of their care, according to a Health Council of Canada bulletin released today.
Novartis today announced that both the US Food and Drug Administration and European Medicines Agency have accepted the company's New Drug Application and Marketing Authorization Application respectively, for investigational oral, once-daily siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis in adults.
ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announced today that Symphony Technology Group (STG), has acquired a majority ownership interest in the Company. STG is a leading private equity firm with a strategic focus on data, analytics and technology-enabled services companies. Merck Capital Ventures (MCV), the venture capital arm of Merck and one of ImpactRx's existing investors, will maintain its investment in ImpactRx.
› Verified 2 days ago
Apria Healthcare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8550 N 91st Ave, Peoria, Arizona 85345 Phone: (623) 872-1392 | |
The Oxygen Store Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8581 W Kelton Ln, Peoria, Arizona 85382 Phone: (623) 972-0497 | |
Cvs Pharmacy #03745 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 10727 W Olive Ave, Peoria, Arizona 85345 Phone: (623) 815-8238 | |
Cvs Pharmacy #05794 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9069 W Lake Pleasant Pkwy, Peoria, Arizona 85382 Phone: (623) 376-0549 | |
Cvs Pharmacy #07115 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7530 W Cactus Rd, Peoria, Arizona 85381 Phone: (623) 334-4635 |